Sees FY26 reported revenue up 2.5%-4.5%, with constant currency revenue up 2%-4% and organic constant currency revenue up 1%-3%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Notable companies reporting before tomorrow’s open
- ZBH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Zimmer Biomet price target lowered to $86 from $88 at UBS
- Zimmer Biomet: Multi‑Year Turnaround Story Underpins Upgrade to Buy and $109 Price Target
- Zimmer Biomet assumed at Buy from Hold at TD Cowen